Video collection: Read & Publish and Open Access
The Company of Biologists has been committed to Open Access since 2004 and we have a track record of innovation. We were one of the first not-for-profit publishers to launch a cost-neutral Read & Publish Open Access initiative and our hybrid journals were the first in the world to be afforded Transformative Journal status by Plan S.
Our Read & Publish initiative has gone from strength to strength, and corresponding authors at over 900 institutions in 52 countries now benefit from fee-free Open Access publishing in our journals as well as access to the journals and their backfiles.
We have had wonderful feedback about our Read & Publish initiative from librarians, authors and Editors-in-Chiefs. Hear what they say in our expanding collection of videos.
We have also recorded a series of general and introductory videos on key topics in Open Access publishing – from transformative Journals to transparent metrics.
Read & Publish - what Editors-in-Chief say
Editor-in-Chief, Daniel Gorelick, talks about Biology Open, the importance of Open Access publishing and how The Company of Biologists’ Read & Publish initiative benefits researchers.
Craig Franklin (Editor-in-Chief of Journal of Experimental Biology) talks to Claire Moulton (Publisher at The Company of Biologists) about the benefits of Read & Publish agreements and how they are helping to increase the proportion of Open Access content in his journal.
Why is Open Access important? Are Read & Publish agreements supporting the move to OA? Hear what the Editors-in-Chief of Development, Journal of Cell Science and Journal of Experimental Biology say.
Editor-in-Chief, Liz Patton talks about Disease Models & Mechanisms, the importance of Open Access publishing, and how the fact that the journal is now included in our Read & Publish initiative benefits researchers.
Editor-in-Chief, James Briscoe, talks about Development, the importance of Open Access publishing and how our Read & Publish initiative benefits researchers.